Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Knight

Showing results (141-150 of 165) with videos related to

Pageof 17
Sort By:
Biochimica Et Biophysica Acta|December 15, 2015
Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenaseXingsheng Li, John Knight, Sonia Fargue, et al.
Innovations (Philadelphia, Pa.)|March 23, 2012
Off-Pump versus Conventional Coronary Artery Bypass Grafting: A Meta-Analysis and Consensus Statement From The 2004 ISMICS Consensus ConferenceJohn Puskas, Davy Cheng, John Knight, et al.
Journal of the American Society of Nephrology : JASN|July 20, 2016
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary HyperoxaluriaAbigail Liebow, Xingsheng Li, Timothy Racie, et al.
The Lancet. Planetary Health|December 14, 2024
The potential for reducing greenhouse gas emissions through disease prevention: a secondary analysis of data from the CREDENCE trialBenjamin Talbot, Robert A Fletcher, Bruce Neal, et al.
Health Technology Assessment (Winchester, England)|September 13, 2024
Clinical and cost-effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic modelJoe Carroll, Catalina Lopez Manzano, Eve Tomlinson, et al.
BMC Nephrology|September 6, 2024
Tubulointerstitial nephropathy is the predominant finding in men in a review of more than 3000 renal biopsies over a 10-year period from Sri LankaJennifer Pett, Christine Linhart, Nicholas Osborne, et al.
BMC Nephrology|October 29, 2024
Correction: Tubulointerstitial nephropathy is the predominant finding in men in a review of more than 3000 renal biopsies over a 10-year period from Sri LankaJennifer Pett, Christine Linhart, Nicholas Osborne, et al.
The Annals of Thoracic Surgery|March 22, 2008
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION studyRobert M Mentzer, Claus Bartels, Roberto Bolli, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2024
The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis systemBenjamin Talbot, Simon Davies, Jenny Burman, et al.
Lancet (London, England)|March 18, 2015
Worldwide access to treatment for end-stage kidney disease: a systematic reviewThaminda Liyanage, Toshiharu Ninomiya, Vivekanand Jha, et al.
Pageof 17

Showing results (141-150 of 165) with videos related to

Sort By:
Pageof 17
Biochimica Et Biophysica Acta|December 15, 2015
Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenaseXingsheng Li, John Knight, Sonia Fargue, et al.
Innovations (Philadelphia, Pa.)|March 23, 2012
Off-Pump versus Conventional Coronary Artery Bypass Grafting: A Meta-Analysis and Consensus Statement From The 2004 ISMICS Consensus ConferenceJohn Puskas, Davy Cheng, John Knight, et al.
Journal of the American Society of Nephrology : JASN|July 20, 2016
An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary HyperoxaluriaAbigail Liebow, Xingsheng Li, Timothy Racie, et al.
The Lancet. Planetary Health|December 14, 2024
The potential for reducing greenhouse gas emissions through disease prevention: a secondary analysis of data from the CREDENCE trialBenjamin Talbot, Robert A Fletcher, Bruce Neal, et al.
Health Technology Assessment (Winchester, England)|September 13, 2024
Clinical and cost-effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic modelJoe Carroll, Catalina Lopez Manzano, Eve Tomlinson, et al.
BMC Nephrology|September 6, 2024
Tubulointerstitial nephropathy is the predominant finding in men in a review of more than 3000 renal biopsies over a 10-year period from Sri LankaJennifer Pett, Christine Linhart, Nicholas Osborne, et al.
BMC Nephrology|October 29, 2024
Correction: Tubulointerstitial nephropathy is the predominant finding in men in a review of more than 3000 renal biopsies over a 10-year period from Sri LankaJennifer Pett, Christine Linhart, Nicholas Osborne, et al.
The Annals of Thoracic Surgery|March 22, 2008
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION studyRobert M Mentzer, Claus Bartels, Roberto Bolli, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 5, 2024
The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis systemBenjamin Talbot, Simon Davies, Jenny Burman, et al.
Lancet (London, England)|March 18, 2015
Worldwide access to treatment for end-stage kidney disease: a systematic reviewThaminda Liyanage, Toshiharu Ninomiya, Vivekanand Jha, et al.
Pageof 17